News

So, what's the tea on microdosing? It's pretty much what it sounds like — taking smaller doses than the usual prescribed ...
The rising trend of sweet-smelling gourmand fragrances coincides with anecdotal reports from GLP-1 weight-loss drug users ...
Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...
TikTok just made a move aimed to help protect teen girls ’ mental health — but it feels like too little, too late. The social media app announced that they banned the hashtag “SkinnyTok” from being ...
U.K. regulators issued guidance on Thursday, warning weight loss and diabetes medications may weaken the effectiveness of ...
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.
The FDA has not approved any oral GLP-1 medications, nor has it approved the use of GLP-1 medications for cosmetic purposes.
Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...
PepsiCo offers rising income, strong global growth, and undervaluation despite market headwinds, supporting a bullish outlook ...
Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...
While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...